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Abstract
Corneal transplantation is an important surgical treatment formany common corneal diseases.
However, aworldwide shortage of tissue from suitable corneal donors hasmeant thatmany people are
not able to receive sight-restoring operations. In addition, rejection is amajor cause of corneal
transplant failure. Bioengineering corneal tissue has recently gainedwidespread attention. In order to
facilitate corneal regeneration, a range ofmaterials is currently being investigated. The ideal substrate
requires sufficient tectonic durability, biocompatibility with cultured cellular elements, transparency,
and perhaps biodegradability and clinical compliance. This review considers the anatomy and
function of the native cornea as a precursor to evaluating a variety of biomaterials for corneal
regeneration including key characteristics for optimalmaterial form and function. The integration of
appropriate cells with themost appropriate biomaterials is also discussed. Taken together, the
information provided offers insight into the requirements for fabricating synthetic and semisynthetic
corneas for in vitromodeling of tissue development and disease, pharmaceutical screening, and in vivo
application for regenerativemedicine.
1. Introduction
The cornea is a transparent, avascular and highly
innervated tissue located at the anterior part of the eye.
Its primary functions are to transmit and refract light
entering the eye and to protect the eye from mechan-
ical damage, UV light, and infection. Corneal trans-
plantation is an important surgical treatment for
injury and disease [1]. TheWorldHealthOrganization
(WHO) 2010 global survey estimated 39 million
people with blindness. 12% or 4.9 million have
bilateral corneal blindness [2]. From regional surveys,
23 million people are estimated to suffer from
unilateral corneal blindness globally [3]. The causes
of corneal blindness are diverse and include various
corneal dystrophies, infectious and inflammatory
corneal disorders, and corneal surface damage.
Corneal transplantation remains an important
treatment for corneal diseases/conditions, with 72%
of recipients showing visual improvement [4]. How-
ever, several unfavorable factors impede the utilization
of corneal transplantation. In particular, although
allogeneic tissue from human donors remains the best
option for corneal graft replacement, this approach is
hindered by the shortage of donor tissue and by trans-
plant rejection [5].
A global survey on corneal transplantation showed
there were a total of 184 576 corneal transplantations
conducted in 116 countries and 284 000 corneas pro-
cured in 2012 [6]. It also reported a substantial lack of
tissue with only one cornea available for every 70
patients worldwide [6]. The incidence of immunologic
corneal graft rejection has decreased compared with
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being avascular, an immunosuppressive ocularmicro-
environment, and the phenomenon of anterior cham-
ber-associated immune deviation. Nevertheless, a
recent study during a five year follow-up shows 23%of
subjects experienced at least one rejection event after
penetrating keratoplasty (PK) [7]. Normally, corneal
immunologic rejection can be reversed with topical
steroids, but severe rejection can lead to fast and per-
manent loss of endothelial cells and transplant failure.
If no clinical improvement occurs, the only option is
to surgically remove and replace the damaged cornea
with a further corneal transplant [5, 8]. What is more,
corneal rejection can result in permanent blindness
[9]. Therefore, allogeneic corneal transplantation has
limitations and a bioengineered cornea could poten-
tially address the key issues of tissue availability and
tissue rejection.
The first full-thickness PK was performed on 7
December 1905 by Dr Eduard Zirm [9]. The first case
of lamellar keratoplasty (LK; removal of anterior layers
of the cornea)was successfully conducted prior to this,
but early outcomes were poor [10]. With the develop-
ment of microsurgical instruments, and improved
surgical techniques in the past ten years, selective
lamellar keratoplasty (SLK; removal of diseased layers
of corneas only), as the successor to LK, has sig-
nificantly improved keratoplasty [1]. Specifically, SLK
consists of anterior lamellar keratoplasty (ALK) and
endothelial keratoplasty (EK). ALK replaces the epi-
thelium and stroma, while retaining the uninfected
healthy stroma and endothelium. Alternatively, a deep
anterior lamellar keratoplasty (DALK) is performed if
almost all the stroma has to be removed. DALK has
been successfully used in treating keratoconus patients
[11]. In contrast, EK replaces only Descemet’s mem-
brane and the endothelium, and is mainly used for
corneal disease caused by endothelial disorders or fail-
ures. Compared to PK, ALK and DALK are less likely
to cause loss of the host endothelial cells and thereby
avoid endothelial rejection. EK can theoretically pro-
vide better visual outcomes due to improved astigma-
tism [1]. Recently, the frequency of lamellar
procedures has been steadily increasing [12]. None-
theless, all the above-mentioned techniques use donor
corneas and therefore graft tissue availability and
rejection remain challenging.
Since the discovery of limbal stem cells (LSCs),
autologous or allogenic limbal tissue transplantation
have been considered for reconstructing the injured
ocular surface [13]. For patients with unilateral limbal
stem cell deficiency (LSCD), a limbal autograft from
the healthy contralateral eye is the best option for
avoiding tissue rejection [14]. By contrast, the treat-
ment for severe bilateral ocular surface disease is lar-
gely dependent on procuring allogeneic tissue from
the limbal region of corneal tissue donors [13]. Bene-
fits aside, it remains difficult to estimate the appro-
priate amount of limbal tissue from a donor eye for
autologous transplantation. Inadequate volume may
lead to the failure of eye surface-reconstruction and
excess extraction tends to impair the healthy donor
eye. Amniotic membrane (AM) has commonly been
used as a natural substrate for limbal epithelial cell cul-
ture and delivery, but the potential for infection and
the shortage of source tissue necessitate better alter-
natives [15]. Similarly, for reversible blindness caused
by corneal endothelial cell failure, there is an urgent
need for cell carriers to replace the failed endothelium
with ex vivo expanded endothelium cells [16].
In this review, we provide an overview of the anat-
omy and function of the native cornea as the primer to
a systematic summary of various biomaterials and
methods for corneal engineering, including key char-
acteristics for optimalmaterial form and function, and
suitable cells formaterial interfacing.
2.Human cornea anatomy and function
The human cornea is the first tissue through which
light enters the eye and accounts for two thirds of the
refractive power of the eye, directing the light rays
towards the pupil [17]. Anatomically, the cornea is
wider along the horizontal meridian compared to
vertically. Population studies indicate the average
horizontal diameter of the cornea in adults is around
11.80 mm [18, 19], and the vertical diameter is around
10.63 mm [20]. The radius of the corneal curvature is
steepest at the center and flattens towards the periph-
ery, with a mean central radius of curvature being
approximately 7.7±0.30 mm [21]. Until recently,
the cornea was understood to comprise five layers,
including anterior to posterior: epithelium, Bowman’s
layer, stroma, Descemet’s membrane and endothe-
lium (figure 1). In 2013, Dua et al reported a sixth layer
termed pre-Descemet’s layer that lies between the
stroma and Descemet’s membrane [22], although
there is still controversy around its existence. Among
these layers, the epithelium, stroma and endothelium
are cellular layers, whereas Bowman’s layer, pre-
Descemet’s layer and Descemet’s membrane are
acellular layers (figure 4).
The cornea is one of the most innervated tissues of
the body, with the majority of nerves being sensory
and derived from the ophthalmic division of the tri-
geminal nerve (5th cranial nerve) [23]. The nerve bun-
dles enter the cornea through the limbus where they
form the limbal plexus, then extend to the peripheral
corneal stroma. The stromal nerve bundles start to
branch at the mid-peripheral area, passing through
Bowman’s layer forming the sub-basal nerve plexus
that locates in the basal epithelial layers. Individual
nerve fibers arising from the sub-basal plexus move
anteriorly and terminate in the superficial epithelium
as free nerve endings [23]. Corneal nerves are impor-
tant for both protection and maintaining the integrity
of the ocular surface, and corneal sensation and nerve
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density are important indicators for cornea recovery
after surgery [23, 24].
2.1. Corneal epithelium
The corneal epithelium is the outermost layer of the
cornea and themajor refractive element of the eye. It is
40–50 μm thick and consists of 4–6 layers of stratified
and nonkeratinized squamous epithelial cells [17]
(figure 2). The most superficial corneal epithelial cells
form 2∼3 flat layers with glycocalyx-covered micro-
villi on the top surface. The glycocalyx is indispensable
for the stability of tear film, which in turn contributes
to normal vision. These surface cells form tight
junctions that prevent tears, toxins andmicrobes from
entering the eye. Immediately below the superficial
cells is the middle wing cell layer, and the inner basal
columnar layer. The basal cell layer is approximately
20 mm thick and the source of wing and superficial
cells and, apart from LSCs and transient amplifying
cells, are the only corneal cells capable of mitosis [25].
Furthermore, the basal cells are firmly connected to
each other by lateral gap junctions and zonulae
adherens and strongly attached to underlying basal
lamina by hemidesmosomes [25].
Corneal epithelial cells regenerate every 7–10 days
through centripetal migration starting from the lim-
bus, located on the corneal rim at the junction
between the sclera and cornea (figure 3) [26]. The
limbus contains corneal epithelial stem cells that
are important for corneal epithelial homeostasis
(figure 4(C)). The stem cells divide asymmetrically to
produce transient amplifying cells, which migrate
towards the central cornea to become basal central
corneal epithelial cells. These cells then further differ-
entiate and migrate towards the corneal surface to
become the wing and superficial corneal epithelial
cells (figure 3) [27]. In the normal resting state, p63 is
totally absent in the corneal epithelium. When wound
Figure 1.Cross-sectional schema of the cornea.
Figure 2.Cross-sectional schema of the corneal epithelium.
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healing occurs, the αisoform of∇Np63 (N-terminally
truncated transcripts generated by the p63 gene) was
reported to be significant to identify the stem cells that
reside in the basal layer of the limbus.∇Np63α, is an
indicator for the regenerative proliferation of the cor-
neal epithelium and can also be detected in the central
cornea due to the migration of LSCs once activated
[28]. Themain function of the corneal epithelium is to
form a barrier to prevent toxins and microbes from
entering the epithelium, integrate with tears to provide
a smooth layer for light refraction, and transfer water
and soluble components into or out of the stroma
[29]. The most posterior layer of the epithelium is a
basement membrane (BM), where the basal epithelial
cells attach. The BM is about 40–60 nm thick and con-
sists of type IV collagen, laminin, perlacan (a heparin
sulfate proteoglycan), and nidogen (a sulfated glyco-
protein) [30]. Together, the BM is essential for the
adhesion and polarity of the epithelial cells, and to
modulate cellular signaling and trafficking between
the epithelium and stroma [30].
2.2. Bowman’s layer
Between the epithelium and stroma layers lies the
Bowman’s layer (figure 1), which has a smooth
anterior surface abutting the epithelial BM, with its
posterior side merging with the stroma [31]. The
Bowman’s layer is acellular and has numerous pores
allowing the passage of nerve bundles [31]. It consists
mainly of collagen types I and III, as well as types V and
VI [32–34], which formcollagenfibrils with a diameter
of 20–25 μm. The individual collagen fibrils intercon-
nect to generate a sheet about 8–12 μm [35]. The
thickness of the Bowman’s layer decreases with age
[35] and it does not regenerate following trauma or
removal [31]. It is hypothesized that the Bowman’s
layer is formed early in the development of the cornea
via the interaction between the corneal epithelial cells
and keratocytes in the stroma [36]. Its absence does
not appear to prevent re-epithelialization following
surgery or trauma [36]. However, the Bowman’s layer
has been reported to assist with stromalwound healing
and restoration of the subepithelial nerve plexus [31].
2.3. Stroma
The corneal stroma accounts for roughly 80%–85% of
the entire corneal thickness, and affords many bio-
chemical properties of the cornea including tensile
strength, stability and transparency [30]. The collagen
fibrils in the stroma are bigger than in the Bowman’s
layer with diameters ranging from 25–35 nm [35].
Collagen type I is predominant in the stroma.
Together with type III and V collagen they form
collagen fibrils. Type VI collagen occurs as fine
filaments in the inter-fibrillary matrix of the stroma
[34]. The collagen fibrils form triple-helix bundles
with diameters of 250–340 nm, which align to form a
flat lamellar sheet [35]. The lamella sheets are envel-
oped by proteoglycans decorated with keratin sulfate
or chondroitin sulfate, and preserve corneal hydration
and transparency [37]. The stroma consists of
250∼300 collagen lamellae with a width of
10–320 μm and a thickness of 0.2–2.5 μm [38]. The
arrangement of the lamellae in the stroma is hetero-
geneous, with the collagen fibers being interwoven in
the anterior stroma and parallel in themid to posterior
stroma [38]. In addition, the intervals between lamel-
lae arefilledwith keratocytes, which occupymore than
20% of the stroma. These cells are responsible for the
stability of lamellar organization and regulation of the
corneal stroma extracellular matrix (ECM) compo-
nents via the synthesis of collagen and proteoglycan
[39]. The framework of the corneal stroma is impor-
tant for the transparency and mechanical property of
the cornea.
Once the normal integrity or the interconnection
with the Bowman’s layer andDescemet’smembrane is
interrupted, the stromal wound-healing process is
activated. Due to the distinct avascular nature of the
cornea, a critical difference between stromal healing
Figure 3. Schema of the LSCniche.
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and that of other body tissues such as the skin is the
absence of the vascular component [40].
2.4. Pre-Descemet’s layer andDescemet’s
membrane
The pre-Descemet’s layer is posterior to the stroma
and anterior to the Descemet’s membrane. The recent
discovery of the pre-Descemet’s layer remains con-
troversial with many studies suggesting the layer to be
part of the stroma [22, 41]. However, emerging
evidence of the structure, constitution and clinical
importance support its existence as a distinct layer. It is
made up predominately of type I collagen but includes
type VI collagen, which assembles into 5–8 thin
Figure 4. Light-microscopic image of the human cornea stainedwith hematoxylin and eosin. A human cornea is uniformly thick
across the central regionwith increased thickness towards the limbus. B. Cross-sectional image showing the six-layered corneal
structure. C. Enlarged image of the limbus showing the presence of blood vessels and an undulating basal epithelium (asterisks).
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lamellae with an overall thickness of 10–15 μm [22]. A
recent study suggests that it consists of high levels of
elastic fibers that originate within the posterior limbus
in the trabecular meshwork [42]. This elastic fiber
network in the pre-Descemet’s layer could be impor-
tant for anchoring the cornea as well as the trabecular
meshwork to the limbus and peripheral cornea [42].
The clinical importance of the pre-Descemet’s layer is
supported by the big bubble technique being unsuc-
cessful if the layer is disrupted [43]. The predominant
collagen in the Descemet’s membrane is type IV,
although it also includes collagen type VIII, XII,
laminin, perlecan, nidogens, vitronection and fibro-
nectin [44]. In contrast to the Bowman’s layer, its
thickness gradually increases from birth to adulthood,
expanding to between 5–10 μm [45]. It is secreted by
the endothelial cells to form the BM for the endothelial
cells to anchor [45].
2.5. Endothelium
The human corneal endothelium (HCEN) is com-
posed of a single layer of hexagonal-shaped cells with
a thickness of around 5 μm. Similarly, the adjacent
endothelial cells are characterized by a lateral gap
and tight junctions and are vertically attached to the
Descemet’s membrane by numerous hemidesmo-
somes [46]. Once the endothelium layer is formed,
the endothelial cells become mitotically inactive.
The HCEN initially comprises approximately
4500 cells mm−2, with the total endothelial cell
number decreasing with age, while the cell surface
area increases [47]. The main indicator for an eye
bank to select corneas after storage for PK, is the
endothelial cell counts [48]. Generally, donor cor-
neas considered for transplantation need to have an
endothelial cell density of2000 cells mm−2.
While acting as a barrier to restrain fluid into the
cornea, the endothelial cells prevent excessive hydra-
tion (78% water content) of the stroma, maintaining
stromal deturgescence by a passive pump-leak process
that moves ions and water from the hypotonic stroma
to the hypertonic aqueous humor [49]. The whole
process has been shown to be associated with Na+, K
+– adenosine triphosphatase (ATPase) pumps that
reside in the basolateralmembrane [50].
Thus, the endothelium is critical to maintaining
the transparency and nutrition of the cornea via this
‘pump-leak’ mechanism. It is rich in ion and water
channels for the transfer of nutrients from the aqueous
humor to the cornea [51] and its function to nourish
the cornea and inability to regenerate, renders it key to
determining by assessment the suitability of the cornea
for transplantation.
Due to their mitotically inactive nature, once the
number of endothelial cells decreases, the surround-
ing cells gradually infiltrate the vacant region to
maintain tissue integrity. The deformation of the
endothelium, however, tends to impair the pump
function [52].
3. Biomaterials for corneal engineering
Biomaterials employed for engineering corneal sub-
stitutes must replicate the structural and functional
requirements of the native cornea. Briefly, as scaffolds
for cell support, materials must have suitable mechan-
ical toughness, biocompatibility, transparency, appro-
priate biodegradability, and be clinically compliant.
Commonly used biomaterials broadly include natural
and synthetic polymers. While natural polymers tend
to have excellent biocompatibility, synthetic polymers
enable customization of the desired properties. The
characteristics of extant materials determine their
application (tables 1 and 2).
3.1. Collagen
Collagen is the most abundant component of ECM in
most tissues [53, 54], with tripeptide arginine-glycine-
aspartic acid (RGD) recognized by the cell surface
integrin receptors, being important for cell adhesion,
migration and proliferation [55]. The widespread
application of collagen (especially collagen type I) in
tissue engineering is partly due to its ease of produc-
tion. Collagen type I is a key component to the tendon,
ligament and dermis and is relatively cheap to derive.
Collagen is therefore vital to fabricating biomimetic
corneal stroma equivalents as the main component of
human stromal tissue [56–58], and is compatible with
all corneal cells and nerve regrowth in vivo [55, 59–62].
The primary drawback of collagen, however, is insuffi-
cient mechanical toughness and elasticity [63, 64].
Therefore, crosslinking collagen has been widely
applied to considerably improve its mechanical
strength and chemical stability without compromising
the biological advantages. Importantly, the source of
collagen impacts on the physical properties of the final
product. For instance, the addition of soluble tropo-
collagen improves transparency and strength [65], and
while both type I and type III collagen hydrogels have
adequate tensile strength and elasticity for handling,
type III collagen hydrogels tend to be mechanically
and optically superior [66, 67].
Themethods which have been investigated for col-
lagen crosslinking for bioengineering mainly include
chemical, physical and enzymatic approaches. Alde-
hydes such as formaldehyde and glutaraldehyde, the
carbodiimide family (EDC), isocyanate chemical
family (hexamethylene diisocyanate) and genipin are
commonly used for the chemical crosslinking of col-
lagen [68]. Physical crosslinking involves ultraviolet
(UV) or dehydrothermal treatment and enzymatic
crosslinking with transglutaminase can enhance the
mechanical toughness of collagen without generating
toxic by-products [68]. However, not all of these
methods are commonly employed in corneal
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Table 1.Biomaterials used for corneal bioengineering.
Material N/Sl Processingmethod Pros Cons Applications Biocompatibility Transparency
Mechanical
toughness Biodegradability Permeability Clinical status




Corneal stromal equivalents; ++++ +++ + ++++ +++ Clinical follow-up
48monthsCollagen-vitrigel; Substrate for corneal epithelial and
endothelial bioengineeringCompression







Corneal stromal equivalents; substrate
for corneal epithelial cells; corneal
fibroblasts and corneal endothelial
cells
++ ++++ +++ +++ +++ Animalmodel
Electrospinning
Gelatin N Evaporation; Natural biocompatibility;
suitable biodegradability
Inferior Substrate for +++ +++ + ++++ +++ Animal
Crosslinking mechanical properties corneal endothelial cell transplantation
and corneal stromal cell growth
model







Substrate for corneal epithelial regen-
eration and delivery and for endo-
thelial cell growth
++ +++ ++ ++++ ++++ Animalmodel
Composition and crosslinking
DCa N Decellularization Similarmechanical and






Substrate for corneal endothelial regen-
eration and epithelial and anterior
stromal reconstruction
++ ++++ +++ +++ None Animalmodel
SSb N Coating; evaporation High biocompatibility Inferiormechanical
property
Substrate for human corneal limbal epi-
thelial cell
+++ None ++ None None In vitro
Fibrin/Agarose N Polymerization Excellent optical properties Complicated process Keratocytes encapsulated corneal
stroma equivalent
+++ ++++ None None None In vitro






Substrate for corneal epithelial and stro-
mal regeneration and delivery
+ + None ++ None In vitro
PHEMAd S Crosslinking Favorable transparency Surfacemodification
required
Substrate for limbal epithelial cells + ++++ ++++ + None In vitro






Substrate for corneal epithelial cells;
epithelial wound healing













Material N/Sl Processingmethod Pros Cons Applications Biocompatibility Transparency
Mechanical
toughness Biodegradability Permeability Clinical status
PLGAf S Evaporation High transparency Surfacemodification
required
Substrate for corneal endothelial
regeneration
+ ++++ None +++ None In vitro
PEGg/PAAh hydrogel S Polymerization and crosslinking High transparency and glu-
cose permeability
Complicated process Corneal stroma and epithelial
reconstruction
++ ++++ ++ ++ ++++ Animalmodel
PGSi S Polycondensation Favorable biodegradability Complicated process Substrate for human corneal epithelial
cells
++ None None None +++ None
PEUUj S Electrospinning Excellent biodegradability Complicated process Substrate for corneal stromal cell
growth and regeneration
++ None None ++++ None In vitro
Thermoresponsive
materials




are too fragile for
surgical
manipulation
Substrate for corneal endothelial sheets
and epithelial sheets
++ None None None None Animalmodel
(Cell sheets)
PAk S Self-assembly (in solution and
coating)
Versatile and easily designed Complicated process Design 2D and 3D structures for corneal
cells and improve cell performance




























Table 2.Biomaterials and cell sources used for corneal bioengineering for each cellular layer.
Materials Cell sources
Epithelium Silkfibroin: Primary human corneal limbal epithelial cells
Silkfibroinmembrane [93, 95, 100] [56, 70, 72, 79, 87, 89, 90, 93, 95, 100, 104, 107, 121, 129, 141, 152, 160]
Porous silkfibroinmembrane [104, 190]
Patterned silk fibroinmembrane [152]
Silk sericin [107]
Collagen: Primary human corneal epithelial cells
Type I collagen gel [55, 59, 83, 89] [78, 80, 89, 142, 143, 151, 154, 190]
FNCa [54] Immortalized human corneal epithelial cells
CVb [56, 86] [54, 59, 60, 67, 71, 82, 83, 129, 148, 150]
Collagen/silk gel [82]
Synthetic hydrogel Immortalized human corneal limbal epithelial cells [153]
PHEMAc [141]
PEGDAd [142, 143, 159]
Decellurized cornea [121, 125]
Chitosan [128] Primary rabbit corneal limbal epithelial cells [55, 117, 163, 166, 194]
Hydroxyethyl chitosan [133]
Thermoresponsive polymer PNIPAAme [134] Primary rabbit cornea epithelial cells [133, 140, 165]
Electrospun scaffold: Primary bovine corneal epithelial cells [128]
PLGAf [163]PHBVg/gelatin [111] Primary porcine corneal limbal epithelial cells [152]
Chitosan/gollagen [129]PCLh/PVAi [166]
Gelatin/PLLAj [165]
Stroma Silkfibroin: Primary human corneal stromal stem cells [164, 170, 181]
Porous silkfibroinmembrane [105, 190]
Patterned silk fibroinmembrane
[96, 97, 101, 158]
Primary human corneal fibroblasts [58, 62, 89, 121, 152, 173–175, 181]
RGDk functionalized silk film [97, 105]
Collagen:
Type I collagen [65, 89, 92] Primary human corneal keratocytes [59, 79, 90–92, 155, 158]
Insoluble type I collagen [65]
CV [56]
PEUUl [164, 180, 181] Immortalized human corneal keratocytes [71, 96, 97, 101, 176]
Gelatin hydrogel [111, 113]
DCm [121, 122]
PLDLAn [155] Primary rabbit corneal stromal cells
Electrospun scaffold: [106, 113, 117, 122, 140, 162, 165, 194]
PHBo/PHBV/PCL [162]
PEUU [164] Primary rabbit corneal fibroblasts precursors [111]
Gelatin/PLLA [165] Primary rabbit corneal stromal fibroblasts [111]
Other animal corneal stromal cells: goat [157]; bovine [148]
Endothelium Gelatin hydrogel [110, 112, 114] Primary human corneal endothelial cells
Gelma [116] [64, 90, 98, 110, 114, 116, 123, 136, 170]
Thermoresponsive polymer:
PNIPAAm [136] Immobilized human corneal endothelial cells [71, 79, 98, 138, 139]
Poly (NiPAAm-co-DEGMA)p [138]
PNIPAAmhybrids [157]
Poly(NGMA)q [137] Primary rabbit corneal endothelial cells
[56, 102, 112, 117, 131, 132, 137, 144, 194]
PVMEr [139]
Chitosan [131]
HECTSs [132] Primary bovine corneal endothelial cells [130, 156]
PCL-chitosan [130]
Silkfibroin [98]
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bioengineering, with some approaches generating
toxic residues in the collagen-based biomaterial.
Unlike glutaraldehyde, hexamethylene diisocyanate
and acyl azide, which act as chemical ‘bridges’ between
collagen molecules, with EDC, collagen molecules are
linked directly. Genipin is a crosslinker with low toxi-
city [69]. A study of various crosslinking methods
demonstrated the inclusion of generation 2 poly-
propyleneimine octamine dendrimers largely ampli-
fies the quantity of amine groups in collagens available
for EDC crosslinking. The membrane produced had
superior optical and mechanical properties compared
with dehydrothermally and glutaraldehyde cross-
linked collagen gels [59]. Another study of collagen
suggested that while UV light induced riboflavin,
crosslinking or the use of genipin, or EDC crosslinking
produced adequate tensile strength, superior strength
was found using the EDC crosslinking group [70].
Another crosslinking method involving UV-induced
glucose, results in collagen membranes with moduli
and ultimate tensile strength comparable to that of the
native human cornea [65].
Normally, crosslinked collagen gel can be pro-
duced in a membrane form that is suitable as a growth
substrate for corneal cells [60] and biomimetic corneal
equivalents [56, 57], or 3D structures with stromal
cells encapsulated or scaffolds seeded with epithelial
and endothelial cells [71, 72]. The latter provides for
the development of full-thickness corneal tissue that is
analogous to a native structure, but has relatively poor
mechanical properties due to incomplete crosslinking
and cell protection [71, 72]. The cytocompatibility of
crosslinked collagen gels has been demonstrated in
numerous studies. For example, dehydrothermally
crosslinked, EDC and glutaraldehyde crosslinked gels
are able to support the growth of human and rabbit
corneal epithelial cells (rCECs), HCFs, and HCEN
cells [55, 58, 60, 62, 71, 73]. In addition to pure col-
lagen hydrogel, collagen-polymer composites have
been reported to further enhance the mechanical
strength and resistance to enzymatic degradation
[74, 75]. For example, porcine type I collagen and
2-methacryloyloxyethyl phosphorylcholine (MPC)
interpenetrating network hydrogels display improved
mechanical strength, and stability, with comparable
optical properties, and glucose as well as albumin per-
meability with those of the native human cornea
[76, 77] enabling the regeneration of corneal cells and
functional nerves in pigmodels. A combination of col-
lagen with a copolymer from N-isopropylacrylamide,
acrylic acid and acryloxysuccinimide resulted in a
transparent, permeable and robust collagen gel that
prevented excessive collagen fibrillogenesis and was
well tolerated in dogs [74]. A composite collagen-
Table 2. (Continued.)
Materials Cell sources
Full-thickness Silkfibroin [38] Dorsal root ganglion (DRG) cells:
Fibrin [192, 193] from chick embryos [66, 76, 190]
Collagen gel:
Type I collagen [60] Human embryonic stem cells (hESCs) [127]
Type I and type III collagen [66]
Collagen I and copolymer [74–77] [79]
CV [57]
DC [117, 118, 126, 127]
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chitosan membrane demonstrated better mechanical
toughness and optical properties and when trans-
planted into a pig cornea, allowed the regeneration of
the epithelium, stroma and nerve in 12 months
[63, 78]. The incorporation of chondroitin sulfate into
collagen gels tends to lead to higher mechanical prop-
erties and moisture retention [73, 79]. Crosslinking
tobramycin into collagen, a novel antibacterial col-
lagenmembrane with excellent antibacterial effect can
be obtained [80]. The incorporation of cyclodextrin in
collagen membrane is capable of improving the trans-
parency as a result of reduced collagen fibrogenesis
[81]. Enhanced mechanical properties can also be
achieved by the integration of silk fibroin [82]. Duan
et al reported that the incorporation of YIGSR
(a model cell adhesion peptide) modified dendrimer
into collagen gel promoted the adhesion and prolifera-
tion of human corneal epithelial cells (HCECs) as well
as neurite extension from dorsal root ganglia [83].
While most collagen structures reported are flat,
Zhang et al recently produced a natural corneal-
shaped collagen membrane by placing dethermally
crosslinked collagen in a rigid contact lens mold and
then incubated it at 37 °C for complete dehydration
[70]. By loading a compressive force on the dehy-
drothermally crosslinked collagen gel, plastic com-
pression (PC) collagen with improved mechanical
toughness has been explored as a carrier to expand the
HCEN cell for transplantation [84]. The PC collagen
films, however, are not easily manipulated. To solve
this issue, electrospun PLGA films were then used to
form a sandwich-like structure for transplantation.
The light transmittance of the structure, however, is
insufficient, being less than 80% under a 500 nm
wavelength [85]. Other composites include collagen-
vitrigel (CV), a collagen-based product with enhanced
gel strength by vitrification [86]. Briefly, themixture of
collagen, FBS, N-2-hydroxyethylpiperadine-N0-2-
ethansulfonic acid buffer and Dulbecco’s modified
eagle medium was incubated at 37 °C and 5% CO2 for
2 h gelation. Under controlled humidity, the gel was
vitrified into a glass-like material. Finally, the CVs
were rehydrated to obtain a regenerated and stable CV
membrane. During the whole process, the CV can be
tailored for transparency and mechanical strength by
optimizing the synthesis conditions [87]. Moreover,
the CV has been shown to facilitate epithelial layer
generation in vitro [56], and exhibits sustained tissue
transparency and low inflammatory response [86].
To date, collagen is the most extensively used mat-
erial in corneal bioengineering (table 3). Overall, col-
lagen scaffolds, either pure or hybrid, provide
excellent support of cells derived from different cor-
neal tissue layers. The main challenge for tissue engi-
neers using collagen for corneal bioengineering is the
fabrication of collagen constructs that mimic the well-
organized structure and cell-encapsulation ability of
the corneal stroma [88]. Griffith et al created a multi-
layered corneal matrix by seeding epithelial cells and
endothelial cells on the top and bottom of immobi-
lized human corneal keratocyte-encapsulated glutar-
aldehyde crosslinked collagen-chondroitin sulfate
substrate [71]. Similarly, German et al reconstructed a
cornea by seeding primary HCECs on primary human
fibroblasts encapsulated dehydrothermally into a
crosslinked collagen gel. After 3 days in culture, 4–5
layers of the regenerated corneal epithelium and com-
ponents of BM were detected [89]. Keratocytes have
been incorporated into porous collagen sponges by
crosslinking and lyophilisation [90]. The keratocytes
migrated into the pores and evidence of matrix secre-
tion and elongated cell morphology was observed.
Controlling the organization of collagen fibrils to
mimic the corneal stroma has long been of interest
when utilizing collagen for corneal bioengineering.
Builles et al reported that scaffolds of orthogonal
lamellae composed of aligned collagen fibrils can be
formed by the gelation of collagen in a horizontal
magnetic field, mirroring the inner structure of the
human corneal stroma (HCS) [91, 92]. Interestingly,
keratocyte alignment is directed by the collagen orien-
tation both on the surface and within the bulk of the
scaffold [92]. Although the scaffold possesses similar
structure to human cornea stroma, it is not transpar-
ent probably due to the relatively large diameter of col-
lagen fibrils. Proteoglycans were thus incorporated
into the scaffold to improve the transparency.
Although the as-prepared scaffolds demonstrated
great potential for the recovery of the anterior cornea
in the rabbit model, the graft retention, however, still
needed to be improved through the optimization of
crosslinking [92].
3.2. Silk
Silk fibroin (SF) is a structural protein derived from
the cocoon of the silkworm bombyx mori and has been
widely used in tissue engineering and regenerative
medicine, because of its non-immunogenic response,
controllable degradation rates andmechanical proper-
ties. Normally, pure silk solution, the precursor of the
diverse SF framework, is obtained by mixing SF with
lithium bromide solution before dialysis. In the
context of corneal engineering, the inherent optical
clarity of SF undoubtedly makes it a promising
candidate. SF membranes have largely been investi-
gated as substrates for corneal epithelial cells. Pure and
permeable SF membrane generated by simple eva-
poration [93] or electrospinning [94] is able to support
the formation of a confluent multilayered epithelium
and the growth of human corneal limbal epithelial
(HCLE) cells similar to the AM, which is the current
standard substrate used for corneal epithelial cell
transplantation. Although pure SF membrane pro-
vides for similar cell attachment ofHCLE cells to tissue
culture plastics, it is inferior to AM due to the lack of
natural ECM proteins [95]. Nevertheless, the RGD
sequence present in collagen can be coupled on the
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Table 3.Collagen used for corneal bioengineering.
CollagenType Processingmethod References Year In vitro study In vivo study
Bovine type I collagen Dehydrothermal crosslinking [89] 1999 Primary human corneal epithelial cells (limbus and center) and
human corneal fibroblasts
None
Bovine type I collagen Dehydrothermal crosslinking [58] 2004 Primary human corneal stromalfibroblasts None
Bovine collagen type I Dehydrothermal crosslinking [62] 2006 Primary human corneal stromalfibroblasts None
Bovine type I collagen and type III collagen Glutaraldehyde crosslinking; EDCa/NHSii crosslinking [59] 2006 Immortalized human corneal epithelial cells None
Porcine type I collagen EDC/NHS crosslinking [61] 2006 None Rabbits andmini-pigs by lamellar keratoplasty
Bovine collagen type I EDC/NHS crosslinking [83] 2007 Immortalized human corneal epithelial cells None
Recombinant human collagens types I and III EDC/NHS crosslinking [66] 2008 Immortalized human corneal epithelial cells Mini-pigs by deep lamellar keratoplasty
Recombinant human collagens types I and III EDC/NHS crosslinking [67] 2008 Immortalized human corneal epithelial cells Rats by selective lamellar keratoplasty
Rat tail type I collagen EDC/NHS crosslinking [79] 2008 Primary cornea limbal epithelial cells; primary human kerato-
cytes; immortalized human endothelial cells;
None
Type I porcine atelocollagen; recombinant
human type III collagen
EDC/NHS crosslinking [76] 2009 Immortalized human corneal epithelial cell line and dorsal
root ganglia
Rabbits by deep lamellar keratoplasty
Type I collagen solution Collagen-vitrigel [56] 2009 Primary human limbal epithelial cells; primary bovine kerato-
cytes; rabbit corneal endothelial cells
None
Recombinant human collagen, type III EDC/NHS crosslinking [177] 2010 None 24month follow-up of a phase 1 clinical study
Type I porcine atelocollagen EDC/NHS crosslinking [77] 2010 Immortalized human epithelial cell line and dorsal root ganglia Pigs by penetrating keratoplasty
Rat tail type I collagen Dehydrothermal crosslinking [87] 2012 Primary human limbal epithelial stem cells and stromal
keratocytes
Rabbits by selective lamellar keratoplasty
Rat tail type I collagen solution Dehydrothermal crosslinking [55] 2011 Rabbit limbal epithelial cell None
Rat tail type I collagen Dehydrothermal crosslinking and plastic compression [81] 2014 Primary human corneal endothelial cells; human corneal
endothelial cell line
None
Fibronectin-collagen treatment [54] 2013 Immortalized human corneal epithelial cells None
Bovine type I collagen EDC/NHS crosslinking [154] 2014 Primary human corneal epithelial cells None
Bovine type I collagen EDC/NHS crosslinking [78] 2014 Primary human corneal epithelial cells None
Bovine type I collagen EDC/NHS crosslinking [82] 2015 Human corneal epithelial cells Rabbits by lamellar keratoplasty
Bovine type I atelocollagen Collagen-vitrigel [86] 2015 None Rabbits by lamellar keratoplasty and LSCDiii
model induced by chemical injuries.
















surface of the SF membrane to enhance the attach-
ment and proliferation of HCLE cells, human corneal
fibroblasts (HCFs) [96, 97], and human corneal
endothelial (HCEN) cells [98] by mediating cell-
substrate adhesion interactions. Interestingly, poly-D-
lysine (PDL)provides comparable support tomodified
RGD [99]. For corneal stromal bioengineering, porous
silk film has been shown to support the construction
of a two-layer structure using HCLE cells and stromal
cells [100], and human corneal stromal stem cells
(hCSSCs) while secreted ECM adhered to the material
[101]. Moreover, enhanced cell viability and well-
maintained morphology of rabbit corneal endothelial
(rCEN) cells have been reported with the incorpora-
tion of natural aloe vera (AV) gel with SF [102]. To
improvemolecular permeability and biodegradability,
porous SF structures were prepared using the porosity
inducing agent poly(ethylene glycol) (PEG). The
porous structure induced by PEG, however, tends to
reduce the growth and stratification of human limbal
epithelial cell (HLEC) growth. It is also noteworthy
that by having high porosity themembranes tend to be
more fragile [100, 103, 104]. Nonetheless, implanted
RGD-functionalized SF films have been shown to keep
their integrity and transparency for half a year without
immunogenic and neovascular responses in rabbit
stroma [105] and notably a faster degradation rate can
be achieved by introducing porosity [101] or combin-
ing propionamide [106].
While fibroin has been extensively investigated in
corneal engineering, another protein from the domes-
ticated silkworm silk sericin (SS) has been consistently
overlooked due to suspected allergenic activity. Recent
interest, however, in the biocompatibility of SS has
resulted in its consideration as a cell growth substrate.
Pure or blended SS membrane showed inferior
mechanical properties, but enhanced HCLE attach-
ment compared with SF, suggesting a potential appli-
cation for corneal epithelium regeneration [107].
Recently, Applegate et al innovatively published a silk
photocrosslinking method using flavin-mononucleo-
tide (FMN), which is a water-soluble variant of ribo-
flavin, to transfer silk solution to a highly elastic and
transparent hydrogel. The materials involved in the
process are all biologically and environmentally
friendly, which makes this technique very promising
for corneal bioengineering [108].
Overall, compared with collagen, the advantage of
using silk is mainly due to the simplicity of production
and modification, as well as the ease of patterning and
preparing the porous structure, which profoundly
impacts the cell behavior of all corneal cells. The depth
and width of grooves, for instance, were found to
affect HCF alignment. Moreover, building a multi-
layered corneal structure using stacked patterned por-
ous silk films or sponge provides a useful 3Dmodel, in
spite of the technique requiring further improvement
with the native cornea consisting of approximately 200
lamellae with a total thickness of 500 microns, while
the stacked silk films have far fewer layers [109]. While
chemical surfacemodification has been investigated to
improve the biocompatibility, further research is
necessary since the proteins in the natural cornea are
varied andmultifunctional. Most of the studies to date
have focused on the correlation between surface pat-
tern and porous structure, with further studies of
in vivo performance (including the influence of poros-
ity and patterning on biocompatibility)necessary.
3.3. Gelatin
Gelatin is a ubiquitous natural material derived
through the hydrolysis of collagen. The application of
gelatin for corneal engineering mainly involves con-
structing membranes for corneal cells through cross-
linking. The applied methods to prepare gelatin
hydrogel generally include dehydrothermal and che-
mical crosslinking. Being dehydrothermally cross-
linked, gelatin is able to provide sheets with better
transparency, elastic modulus, and albumin perme-
ability compared with collagen. In addition, primary
HCEN cells seeded on as-prepared gelatin showed
normal expression levels of ZO-1, Na +/K+-
ATPase, and N-cadherin, and achieved a continuous
endothelial monolayer [110]. Mimura et al reported
chemically crosslinked gelatin using glutaraldehyde,
which was able to support rabbit fibroblast, fibroblast
precursor adherence and ECM deposition, and was
suitable for implantation into a rabbit stromal pocket
[111]. Using EDC/NHS crosslinking and freeze-
drying, gelatin membranes with varying porosity,
Young’s modulus and swelling ratio can be prepared
by varying the concentration of gelatin and cross-
linking parameters [112]. Comparedwith pure gelatin,
the incorporation of chondroitin sulfate (CS) has been
shown to promote the growth of primary rabbit
corneal keratocytes (RCKs). The hybrid gelatin-CS gel,
however, had lower Young’s modulus and resistance
against protease digestion [113]. By adding heparin
during EDC crosslinking, Niu et al prepared an
innovative transparent gelatin scaffold that has the
capacity to enhance the basic fibroblast growth factor
absorption and release kinetics [114]. Furthermore,
the scaffold is sufficientlyflexible to be folded for easier
transplantation and HCEN cells can be grown on the
scaffold, while maintaining their endothelial morph-
ology and critical pumping function. Following trans-
plantation in rabbits, the implanted scaffolds
gradually fuse with the surrounding stroma [114]. Lai
reported a 3D culture system for RCKs using hyaluro-
nic acid (HA) functionlized gelatin microspheres that
supported the large-scale growth of RCKs. Invest-
igation of the biocompatibility of microcarriers indi-
cated compatibility with rabbit corneal epithelial,
stromal, and endothelial cells, and they were well
tolerated in the anterior chamber of the rabbit eye
[115]. Semisynthetic gelatin methacrylate (GelMA)
has been increasingly used in tissue engineering due to
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its biocompatibility and more importantly, tunable
physical characteristics produced through radical
polymerization in the presence of a photoinitiator.
Rizwan et al developed a hybrid crosslinked GelMA
hydrogel (GelMA+) by incubating a prepolymer
solution at 4 °C for 1 h before UV crosslinking
(figure 5). The GelMA+ showed superior mechanical
properties due to the smaller and more uniform
distribution of pores and excellent support of HCEN
cells. GelMA+ films seeded with HCECs and trans-
planted into a rabbit model were associated with high
cell viability following transplantation [116].
3.4.Decellularized cornea
Decellularized cornea (DC) has shown potential for
corneal scaffold fabrication due to the similarmechan-
ical and optical properties when compared to a natural
cornea [117, 118] and low immunogenicity [119, 120].
The shortage of suitable corneal tissue as a require-
ment for a human DC remains a limiting factor and
thereforemost studies have employed porcine corneas
or bovine corneas as the source material. Previous
studies have revealed the feasibility of using a DC to
support corneal cell growth in vitro and to facilitate
tissue regeneration in animal models [121–123]. Con-
ventional approaches to decellularize cornea tissue
involve the removal of the cellular component using
non-ionic detergent (e.g. Triton X-100, Sigma, St.
Louis, MO, USA), ionic detergents (e.g. sodium
dodecyl sulfate (SDS) and SD), zwitterionic detergent
(e.g. CHAPS), freezing-thawing, and osmotic shock
with hypotonic or hypertonic solutions [118, 123,
124]. Comparison between Triton X-100, SDS, SD
and CHAPS revealed SDS to be the most effective for
the removal of cellular components. Furthermore,
0.5% SDS was the most optimal concentration for cell
removal, while preserving collagen ECM [118, 124].
Another study of decellularization using TritonX-100,
liquid nitrogen, and poly(ethylene glycol), sodium
dodecyl sulfate (SDS) and sodium chloride (NaCl)
with nucleases found that only NaCl/nucleases com-
pletely removed the cellular component and sup-
ported the growth of fibroblasts and epithelial cells,
while maintaining the integrity of the corneal epithe-
lial BM [121]. Hashimoto et al describe a novel
decellularization method using high-hydrostatic pres-
sure (HHP) without detergents. The advantages of
HHP include the elimination of bacteria and viruses,
and the preservation of collagen that provides a
relatively better mechanical support [125]. Similar to
the HHP method, Huang et al reported a gentle
physical decellularization method using supercritical
carbon dioxide (SCCO2), with less processing time,
lower cost and the elimination of pathogens to prepare
an acellular porcine cornea. Compared to the Triton
treatment, the use of SCCO2 enabled better removal of
proteins with no immune response in a rabbit model
at 6 months follow-up. Importantly, the maximum
load of the DC is reduced, because of the increased
spaces between the collagenfibrils due to the decreased
GAG contents [126]. A final decellularization method
worth noting employs pancreatic phospholipase A2
(PLA2) and SD. This approach preserves proteogly-
cans and the structure of the native corneal stroma,
while removingmost of the xenogenetic cells [119].
By preserving the corneal structure, the DC can
provide excellent functionality with similar optical
and mechanical properties to a native cornea with the
capacity to support the confluent growth of the cor-
neal epithelium, keratocytes, and endothelium, as well
as the ability to degrade slowly while merging with the
surrounding stroma during regeneration of the cor-
neal epithelium and nerve growth [117, 122]. By co-
culturing limbal epithelial cell-like (LEC-like) cells
and corneal endothelial cell-like (CEC-like) cells
derived from hESCs on the two sides of a decellular-
ized porcine scaffold, a full-thickness artificial cornea
substitute with similar thickness and mechanical
properties to a native rabbit cornea was successfully
constructed, with multilayered epithelium-like cells
and a uniform monolayer of CEC-like cells observed.
The thickness, endothelial cell density, and mechan-
ical properties of the construct were similar to that of
native rabbit corneas. Scaffolds could be integrated in
a rabbit model with the restoration of transparency at
an 8week follow-up, indicating theDC to be a promis-
ing substrate for full-thickness corneal bioengineer-
ing [127].
3.5. Chitosan
Chitosan is an abundant naturally derived polymer
that is synthesized by deacetylation of chitin. For
corneal bioengineering, chitosan has primarily been
employed as a substitute for AM as a cell carrier to
reconstruct the ocular surface or endothelium. It has
been reported that primary bovine corneal epithelial
cells (BCECs) seeded on pure chitosan membrane
showed improved proliferation and attached more
quickly than those on AM. Moreover, pure chitosan
membrane is able to preserve the phenotypes of
BCECs similar to AM [128]. Furthermore, chitosan
surface modification can have a positive effect on
generating a monolayer of HCECs, while non-mod-
ified substrates cannot [129]. For endothelial regen-
eration, a chitosan membrane with controllable
biodegradation rates can be achieved by incorporating
polycaprolactone (PCL), a slow degrading synthetic
polymer. BCECs cultured on this blended membrane
showed normal appearance, and proliferated well,
forming a continuous monolayer [130]. In addition to
serving as a potential substrate for HCECs, the
incorporation of chitosan can promote the optical
transparency and mechanical strength of collagen
membranes [78]. Because of the poor solubility of
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chitosan in physiological solvents, the research focus
has been shifted to hydroxyethyl chitosan (HECTS), a
water-soluble derivative of chitosan.With comparable
optical transparency, water content, and higher glu-
cose permeability compared to the natural human
cornea [131, 132], membranes made up of hydroxy-
propyl chitosan, gelatin and chondroitin sulfate can
improve the growth of HCECs and rCEN cells,
promote the growth of primary rCEN cells and corneal
epithelium restoration in vitro and are tolerated well in
the anterior chamber of an in vivo rabbit model
[131–133]. Although chitosan has demonstrated great
potential for corneal bioengineering, it ismore suitable
to be utilized as blended, rather than pure scaffolds.
3.6. Thermal responsive polymers
Stimuli responsive polymers such as poly(N-isopropy-
lacrylamide) (PNiPAAm) and PNiPAAm-based copo-
lymers are being increasingly used in bioengineering,
because of their thermoresponsive hydrophobic and
hydrophilic properties, which enables the detachment
of cell sheets without the use of enzymatic digestion.
The ability to generate carrier-free cell sheets makes it a
promising technique for corneal epithelium and
endothelium engineering. While several publications
support the use of both corneal epithelium [134] and
endothelium cell sheets [135] derived from temper-
ature-responsive substrates, endothelium construction
has attracted the most interest. Using rabbit limbal
epithelial stem cells isolated from rabbit ocular surface,
corneal epithelial sheets with compact multilayered cell
sheet architecture were successfully generated from
PNiPAAm grafted cell culture surfaces using poly
(vinylidene difluoride) (PVDF)membrane and applied
for autologous transplantation. The cell sheets attached
to an exposed rabbit corneal stroma within minutes
without suturing and successfully reconstructed the
corneal epithelium [134]. The structure and function of
HCEN cell sheets detached from pure PNiPAAm are
able to restore corneal clarity without causing inflam-
mation or rejection in rabbit models [135, 136]. The
activity of Na+, K+-ATPase and existence of pump
sites were confirmed in vitro and more importantly,
proper stromal hydration was found and corneal clarity
was gradually restored in the rabbit model [135, 136].
Apart from pure PNiPAAm, copolymerization with
glycidylmethacrylate (NGMA) allows the manipulation
of the critical temperature and comprises epoxy groups
for the incorporation of biomolecules. The use of a
copolymer of N-isopropylacrlamide (NiPAAm) and
diethyleneglycol methacrylate (DEGMA) enables faster
cell detachment with a critical temperature, closer to
the physiological range [137, 138]. Teichmann et al
reported a thermal responsive carrier using poly(vinyl
methyl ether) (PVME) where layer thickness, stiffness,
switching amplitude and bioactive modification can be
Figure 5. Schematic diagramof the fabrication of regular gelatinmethacrylate (GelMA) andGelMAwith hybrid crosslinking
(GelMA+) (Reprinted from [116], Copyright (2017), with permission fromElsevier).
15
Biomed.Mater. 13 (2018) 032002 ZChen et al
coordinated to regulate the initial immortalized HCEN
cell adhesion and detachment of cell sheets [139].
Despite all the advantages, given the thermally detached
cellmonolayers are usually fragile, theuse of compatible
delivery methods is important for the surgical manip-
ulation of sheet grafts. Varied carriers have thus been
investigated for the delivery of constructed epithelial
(PVDF) [134] and endothelial layers (stroma bed and
gelatin) [135, 136].
3.7.Other synthetic polymer hydrogels
A variety of synthetic materials including poly(vinyl
alcohol) (PVA) [140], poly(2-hydroxyethyl methacry-
late) (PHEMA) [141], polyethylene (glycol) Diacrylate
(PEGDA) [142, 143], poly(lactic-co-glycolic acid)
(PLGA) [144] and poly(ethylene glycol)/poly(acrylic
acid) (PEG/PAA)-based hydrogels [145–147] have
also been applied in corneal bioengineering, as either
substrates for corneal cells or artificial cornea sub-
stitutes. While exhibiting excellent permeability, con-
trollablemechanical and optical properties, all of these
materials display poor cell-adhesive function without
surface modification [148]. For example, to improve
the attachment and growth of primary rabbit and
human corneal cells, electrospun PVA, PHEMA
hydrogel and PEGDA hydrogel were modified with
collagen type I, phosphate groups and RGD, respec-
tively [140, 141, 149]. Moreover, hydrogels functiona-
lized with amine can support epithelization using
HCECs [148]. Similarly, collagen type I coated PLGA
films can better serve as substratum for rCEN cells
[144]. An artificial cornea fabricated using ZnS/
PHEMA/PAA hydrogel demonstrated high refractive
index [145] and PEG/PAA hydrogel showed high
glucose permeability, while remaining optically clear
in situ for up to 2 weeks [146, 147]. Recently, poly
(glycerol sebacate) (PGS), a novel biodegradable
elastomer, was cured into films and capable of main-
taining the viability of HCECs. However, there have
been no reports of the mechanical or optical proper-
ties, or in vivo testing to date [150].
4.Material surfacemodification
4.1. Topographicalmodification
The influence of topographical cues and surface
chemical modification are important for cell support
regardless of the tissue type being engineered
[151, 152]. For topographical modification, the most
commonly used technique to create varied patterned
features is soft lithography [101, 116, 151, 153–158].
Briefly, feature-patterned master molds (for instance,
patterned silicon substrates), are covered with PDMS,
cured on the patterned substrate and then removed to
be used as patterned templates for cell seeding.
Anatomically, for corneal epithelial engineering, the
key findings are that HCEC contact guidance is not
only modulated by the scale of the topographical cues
[151] and HCLE cells seeded on patterned silk created
by lithographic techniques but suggest parallel line
patterned surfaces promote initial cell attachment by
36%–54% and more that twofold increase in focal
adhesion localization [153]. In addition, the adhesion
and proliferation rate of HCECs on collagen film can
be promoted by inducing a micro-rough surface using
a freeze-drying technique [154]. Interestingly, for
corneal stromal bioengineering, whilst both the depth
and width of the grooves influence HCFs alignment,
the former appears to play a more critical role for cell
orientation [101]. On poly (L,D lactic acid) (PLDLA)
electrospun nanofibrous substrates, HCS cell orienta-
tion and differentiation can be directed, with stiff and
orthogonally arranged nanofiber layers resulting in
keratocyte-like morphology other than those of HCFs
[155]. Nara et al employed direct-write assembly and
prepared parallel patterned thermos-responsive sub-
strates that can guide goat corneal keratocyte align-
ment. However, these patterned substrates could not
produce complete sheet restoration [157]. To compare
the effect of different topography on endothelial cells,
various kinds of patterns including channels, gratings,
concentric circles, wells and pillars have been studied.
Bovine corneal endothelial cells grown on pillars
provide a lower coefficient of variation of area,
enhanced Na+/K+-ATPase activity and a density of
microvilli similar to the native cornea compared to
other patterns [156]. A similar finding on HCECs
reported by Rizwan et al showed that higher Na+/K
+-ATPase expression was found on the substrates of
square-array and hexagonal-array of 1 mmpillars with
6 mm spacing compared to flat substrate. Specifically,
square-array topography increased ZO-1 and Na+/K
+-ATPase expression higher, while hexagonal-array
induced more favorable cell morphometry such as
high cell densities, low cell areas and homogenous cell
size, thus improving the quality of the regenerated
HCECmonolayer [116].
Apart from stereo lithography, the effect of topo-
graphical modification on corneal cell growth and
subsequently corneal tissue regeneration can be
explored via a noteworthy fabrication technique,
namely electrospinning. Electrospinning is a widely
investigated fiber fabrication method that applies a
voltage between a syringe and a collector to draw fibers
from polymer solutions dispensed by the syringe
[159]. Electrospun scaffolds are increasingly being
investigated to develop biomimetic bioengineered
corneas as a result of the bionic reconstruction of
ECM, which showed the promotion of corneal cell
adhesion, proliferation, migration and differentiation
[129, 160]. In many instances natural materials are
used including SF [94], gelatin [161], collagen [129],
HA [129]) and synthetic polymers PCL [162], PLGA
[163], RGD (PEUU) [164], poly-L/D-lactide (PLDLA)
[155], poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
(PHBV) [162], with the latter characterized by out-
standing mechanical properties. While the use of
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natural materials is limited by inferior mechanical
toughness and therefore handling for surgery, synth-
etic polymers such as FDA approved PLA, PLGA, and
PCL have been employed extensively. The application
of electrospun scaffolds is primarily limited to serve as
substrates for the growth and delivery of corneal cells
and the exploration of cell-substrate interactions.
Electrospun substrate as a replacement for AM to sup-
port the regeneration and delivery of corneal epithe-
lium has been widely investigated. For instance,
(PHBV)/gelatin [160], collagen/chitosan/hyalur-
onate(HA)/PEO [129], PLGA [163] electrospun sub-
strates have been shown to be suitable substitutes for
AM. Gelatin/PLLA-based substrates have been used
to investigate the relationship between HCECs and
keratocyte cell behaviors and fiber arrangement [165].
HA/PEO electrospun film was characterized with
excellentmechanical properties, and comparable opti-
cal and biological performance in vivo for rabbit ocular
restoration [129]. Ortega et al electrospun biodegrad-
able PLGA fibers onto PEGDA ring with micro-
features to mimic corneal limbus with the rabbit
corneal limbal epithelial cells well attached and pro-
liferated on the designed microstructure [159]. Fur-
thermore, PCL electrospun nanofibers support HCLE
cell phenotype to facilitate cornea epithelium con-
struction and promote the cell attachment of rabbit
LSCs and rabbit keratocytes [162]. Notably, PLGA
electrospun scaffold is not only biocompatible with
HCS cells but capable ofmaintaining a keratocyte phe-
notype [155] and multilayered rabbit limbal epithelial
cells [163]. Apart from the choice of material, the ease
of manipulating mechanical properties, transparency
and biological properties is also determined by poly-
mer components, special arrangement and functiona-
lization [165–167]. For example, the degree of
alignment of fibers effects the mechanical properties
of scaffolds [165]. Aligned fibers mirror the natural
configuration necessary for cell support and differ-
entiation [161, 168]. For instance, HCS cells cultured
on electrospun PEUU aligned scaffolds tend to secrete
collagenous matrix with similar alignment to natural
corneal stroma [164]. Similar results have shown that
aligned electrospun collagen scaffolds tend to dediffer-
entiate rabbit corneal fibroblasts from the myofibro-
blast phenotype [167]. Salehi et al reported
electrospun nanofibrous PGS/PCL semitransparent
substrate that is able to support the growth of HCEN
cells with hexagonal morphology and direct human
conjunctival epithelial cells growing along the aligned
fibers with the incorporation of PGS improve the cell
proliferation and viability [169]. Earlier studies
demonstrated the potential of electrospun scaffolds in
corneal tissue formation as a result of the favorable
mechanical properties, transparency and the bio-
compatibility with various corneal cells. However, few
in vivo studies have been performed to date.
4.2. Chemicalmodification
Modifications with proteins, peptide and chemical
groups are commonly utilized to promote corneal cell
growth. Apart from the widespread modification of
RGD or collagen on synthetic polymers, carbon chain
length of amine modifications are able to impact the
attachment of epithelial cells and stromal cells [148]. A
study of collagen type I, collagen type IV, fibronectin
(FN), FNC coating mix and laminin modifications
indicate all these coatings facilitate cell adhesion, with
FN coating being the most favorable for HCEN cell
growth and optimum compact cellular morphology
[170]. Interestingly, chitosan coating was also found to
improve the growth ofHCEC line [129].
Peptide amphiphiles (PAs) are peptide-based
molecules typically composed of hydrophilic and
hydrophobic domains and of great interest in tissue
engineering by virtue of their ability to self-assemble
into high-aspect-ratio and highly bioactive nanos-
tructures under certain physical conditions (pH,
temperature and ionic strength) [171]. PA generally
comprises three components: a hydrophobic tail, a
beta-sheet forming amino acid, and a hydrophilic
head that promotes water-solubility and biocompat-
ibility. Self-assembly of PA can be guided by the
hydrophobic collapse of the tail and achieved by
hydrogen bonding between beta-sheet forming amino
acids (figure 6). More specifically, hydrophobic tails of
PAs were internalized and the hydrophilic heads
exposed as bioactive interacting surfaces [172]. For tis-
sue engineering, PAs are commonly applied in differ-
ent formats, including coating, solution and hydrogel
formats. For corneal bioengineering, PA has primarily
been used for coating or in solution due to the inferior
mechanical toughness of hydrogels, able to support a
wide range of corneal cells [171]. As previously men-
tioned, RGD has been widely coated on various bio-
materials to promote corneal cell interaction and
adhesion. In this context, Gouveia at al employed PA
consisting of RGD-containing peptides as a film coat-
ing that was able to enhance the adhesion, prolifera-
tion and alignment of HCFs and enable the
construction of 3D lamellar-like stromal tissue [173].
By also adding a matrix metalloprotease (MMP)-clea-
vable sequence, the PA not only acted as a substrate for
the attachment and growth of HCS cells in a quiescent
phenotype but enabled self-release after adding retino-
tic acid to the culture medium to facilitate the detach-
ment of regenerated stromal matrix from the base
[174]. In addition, Jones et al [175] report a special PA:
C16-KTTKS, which self-assembled into nanotape
structures being able to stimulate collagen I produc-
tion from HCS cells. Finally, Uzunalli et al [176]
applied a laminin-derived sequence YIGSR into PA to
regulate cell adhesion for corneal stroma regeneration.
Compared to RGD-PA, as-prepared PA demonstrated
enhanced cell proliferation, keratocyte migration, and
collagen I synthesis both in vitro and in vivo.
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5. In vivoperformance
Due to the excellent intrinsic biocompatibility, col-
lagen gel, both pure and blended developed by various
kinds of methods, have shown promising perfor-
mances in vivo. From 24 months follow-up of a phase
1 clinical study on the EDC crosslinked collagen gel
scaffold, the fabricated implants remain stable and
avascular, with corneal re-epithelialisation, restored
tear film, recruited stromal cells, and nerve regenera-
tion [177]. Varied hybrid collagen gels, such as
collagen/chitosan [63], glutaraldehyde crosslinked
collagen/TERP [75] were well tolerated in pig corneas
for 12 months and dogs for 16 weeks, respectively.
Being applied as full-thickness implants in guinea pigs,
collagen–MPC hydrogels integrated into host corneas
and promoted regeneration of corneal tissue and
nerves. Electrical activity recorded from the regenerat-
ing corneal nerves suggested that the regeneration of
corneal nerves into the implant started at 3 months
post-surgery and the nerves were functionally active
within the implant by 8months [77].
Although surface modifications are normally
necessary to promote corneal cell growth, silk-based
films have demonstrated favorable in vivo responses.
RGD-functionalized five layers of stacked silk implan-
ted in the lamellar pocket at the limbus in the rabbit
models can maintain their integrity and transparency
over 180 days without causing immunogenic and neo-
vascular responses or degradation of the rabbit corneal
stroma. The regenerated ECM deposited and adhered
well to the surface of the silk films [105]. Porous silk
films prepared using PEG were inserted into stromal
pockets at the limbus of rabbits and were gradually
replaced by corneal stromal tissue, while stromal cells
infiltrated into the silk films without causing inflam-
matory reaction 6 months later. Notably, unlike por-
ous silk films, non-porous ones did not degrade at 6
months [93]. Transparent blended films with aloe vera
gel and SF as a carrier for corneal endothelial cells was
developed by Kim et al by seeding rCECs on the films
to reach confluency. Transplanted into the anterior
chamber of the rabbits’ eyes together, the constructs
attachedwell to the surface of the corneal stroma and 4
weeks later, started to integrate with the surrounding
corneal tissue with the rCECs firmly adhered and
functional. Moreover, rabbit cornea transplanted
using hybrid AV/SF scaffolds with rCECs revealed a
higher corneal transparency compared to that of pure
SF films with rCECs, indicating the improvement of
clarity brought by the AV. However, many constructs
were difficult to insert during the transplantation sur-
gery, because of insufficient mechanical properties
[178]. An investigation on how transplantation tech-
niques affect the biological responses of silk films in
rabbits is stimulating and worthwhile noting. Porous
silk films transplanted into different locations of the
ocular surface (peripheral-median P-M, central-
superficial C-S, central-deep C-D) were used to assess
the in vivo response. The in vivo response of the films
was found to be dependent on the method to create
the corneal pocket, the position of the sample and
sutures. To be more specific, with the use of flushing
air (instead of using a surgical a blade), the C-D posi-
tion (compared to P-M and C-S) and a lack of sutures
resulted in less injury and inflammatory responses.
Two months after the surgery, a comparison of the
degradation of silk films with low, medium and high
beta-sheet (crystalline) content showed that low beta-
sheet samples lost structural integrity, while medium
and high beta-sheet content films remained at the
initial stage [179]. Although fibroin film is designed as
a transplantable carrier, improvement in physical
properties is needed to graft the sheet onto a curved
surface such as the cornea.
One common application of gelatin for corneal
bioengineering is to serve as carriers for endothelial
regeneration and delivery. For instance, EDC cross-
linked intact and porous gelatin carriers have been
inserted into the anterior chamber of rabbit eyes and
no change was observed in the cell morphology of the
rCECs by day 3 [112, 115]. Being implanted into the
anterior chamber of the endothelium-removed rabbit
model, EDC crosslinked heparin-modified gelatin
remained transparent by week 3 with little surround-
ing intraocular inflammation [114]. Glutaraldehyde
crosslinked gelatin seeded with rabbit fibroblast and
fibroblast precursors were transplanted into rabbit
eyes with lamellar dissection.While both carriers were
well tolerated during the 4 weeks follow-up, the gela-
tin/precursor group showed more intense expression
of ECMmolecules [111]. Longer-term observations of
the biological responses of gelatin used in vivo are
however limited.
Due to the well-maintained integrity of ECM, DC
hasdemonstrated excellent biocompatibility in vivo. Por-
cine corneas, decellularized using Tris-HCL [117], SDS
[118], PLA2/SD [119], HHP method [125], SCCO2
[126], have been transplanted into rabbit corneal stroma
pockets to investigate the biological responses. The
implants were normally capable of becoming completely
transparent within 2 weeks, beingmaintained for at least
12 months after transplantation with the implants being
able to support a stratified epithelium with infiltrated
keratocytes. Zhang et aldeveloped a full-thickness cornea
substitute using LEC-like and CEC-like cells derived
from human embryonic stem cells and decellularized
bovine corneas. Being transplanted into a rabbit model
using PK, no significantly high intraocular pressure was
found in the follow-up period. By 8 weeks, the sub-
stitutes werewell integratedwith corneal tissue. LEC-like
cellswere completely replacedbyhost cells and the endo-
thelial cell density of tumor endothelial cells was similar
to that of native rabbit corneas. Compared with a decel-
lularized bovine cornea without cells, the full-thickness
graft showed less neovascularizationwith newblood ves-
sels only in the periphery, while its counterpart was com-
pleted invaded [122].
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Research relating to the in vivo performance of
chitosan is limited. It is reported that after HECTS/CS
blended membranes were transplanted into the ante-
rior chamber of rabbits, the cornea still retained clarity
and no apparent symptoms could be detected [132].
For corneal epithelial bioengineering, rCEC-seeded
chitosan membranes were transplanted onto the ocu-
lar surface in rabbits, promoting corneal recovery
[133] and that chitosan coatings were able to promote
corneal epithelial recovery in a rabbit corneal defect
model [129].
While most synthetic hydrogels are applied as sub-
strates to investigate fundamental cell behaviors, most
of them did not receive in vivo evaluation. As an artifi-
cial cornea, PEG/PAA hydrogel was able to remain
optically clear and show excellent tolerance after being
sutured into the stroma of a rabbit for 2 weeks [146].
A comparison between poly(ethylene glycol) diacry-
late (PEGDA) and poly(ethylene glycol) diacrylamide
(PEG-dAAm) hydrogel showed that in terms of in vivo
biocompatibility in rabbits, the PEG-dAAm-based
hydrogel was superior to the PEGDA-based hydrogel,
with far longer maintenance of corneal clarity up to 6
months, while the PEGDA-based gel implanted ones
showed haze and opacity within 10weeks [147].
6. The importance of cell biology
Considering the different cell types throughout the
cornea and the likely requirement of more than one
type of cell support substrate with a composite of
biomaterials, there is a need for extensive optimization
studies towards merging the components for a com-
plete and functional cornea. For example, electrospun
aligned PEUU substrate [164], combined with growth
factors [180] and the selection between hCSSCs and
HCFs will result in different collagen fibril matrices
and therefore different tissue constructs. Specifically,
multilayered lamellae with orthogonally oriented
collagen fibrils that accurately mimic the HCS tissue
will likely require the combination of fibroblast
growth factor (FGF-2) and transforming growth
factor-beta3 (TGF-b3). Both of these growth factors
Figure 6.Examples of supramolecular self-assembled PAnanostructures: (A)nanofibers; (B)micelles; and (C)multilayered
nanotapes. All three structures have a hydrophilic outer corona consisting of bioactive peptide (blue), self-assembly-inducing/spacer
sequence (white), and a hydrophobic inner core with organized and/or non-organized PA tails (red and green, respectively).
Reprinted from [171]CCBY4.0.
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can stimulate the secretion of collagen from cells
resulting in the directional growth of collagen fibrils
and orthogonal fibril orientation of a collagenous layer
[180]. Regarding cell choice, hCSSCs should differ-
entiate into keratocytes and secrete multilayered
lamellae with well-organized collagen fibrils, while
HCF cells are more likely to differentiate into fibro-
blasts and generate a less-organized collagen construct
[181]. Similar results can be expected for porous
gelatin hydrogel-based constructs, with fibroblast
precursors likely better candidates for corneal stroma
engineering compared with fibroblasts, because of
higher collagen I expression in vivo after implantation
[111]. Moreover, the use of serum tends to induce
hCSSCs to become fibroblastic. In contrast, a kerato-
cyte-like morphology arises in the absence of serum
[155]. Compared to culturing HCECs and stromal
cells alone, co-culturing both cells demonstrated
improved differentiation and growth for both of the
cells [182]. A study on the influence of serum
concentration, oxygen tension for incubation and
macromolecules (carrageenan)-supplemented media
on ECM deposition in HCF culture interestingly
found that the low oxygen tension coupled with
supplemented media in the culture significantly pro-
moted ECMdeposition at day 14 [183].
Practically, the use of seeding cells to differentiate
or modulate the local tissue environment thereby pro-
moting regeneration and repair remains a logical pro-
gression for research. A breakthrough on corneal
epithelial regeneration using tissue-engineered cell
sheets composed of autologous oral mucosal epithe-
lium offered a new treatment for ocular trauma or dis-
ease. After scar tissues on the ocular surface were
removed, cell sheets constructed by culturing oral
mucosal tissue from patients on temperature-respon-
sive polymer poly(N-isopropylacrylamide) were
transplanted into the patients’ eyes. Excitingly, com-
plete re-epithelialization was detectedwithin 1week in
all treated eyes and corneal transparency was restored
and well maintained through long-term follow-up
(mean period of 14 months) [184]. Yang et al pre-
viously showed that human amniotic epithelial cells
could differentiate into conjunctival epithelium-like
cells and goblet cells with partially physiological func-
tion thereby providing successful restoration of ocular
surface integrity in a rabbit model of conjunctival dis-
ease [185].More directly,Mathan et al successfully iso-
lated and transplanted sphere-forming cells from the
peripheral cornea for the potential use of targeting
in vivo ocular surface regeneration and stem cell repo-
pulation [186]. Yet challenges remain. Understanding
the detailed mechanism of differentiation induced by
the niche, the method of immortalization of differ-
entiated cells and the physiological functions of tissue-
engineered surfaces is essential to long-term success.
The microenvironment appears to play an important
role in the directional differentiation and fate of the
implanted cells [187]. As evidence, Mathan and co-
authors found that corneal repopulation differed from
scleral cell repopulation. The authors hypothesized
that inherent characteristics within cells may lead to
preferential changes (i.e. a cell derived from the limbus
would like to reform a limbus or limbal niche). Sepa-
rately, the authors found sphere implantation indi-
cated a similar reactive biological response to the
wounding process. Regardless, current findings pro-
vide tangible evidence to support long-held theoretical
beliefs. The concurrent use of biomaterials may pro-
vide additional benefits and further research is essen-
tial to optimizing an effective approach to corneal
tissue regeneration.
7. Conclusion and future challenges
Over the past few years, many different types of
bioengineered substitutes have been developed to
address the shortage of qualified corneal donors.
Biomaterials used are largely limited to natural poly-
mers able to support cell growth and function in vitro,
and tissue regeneration in vivo. Collagen remains the
best candidate in part due to its excellent biocompat-
ibility from intrinsic RGD, with the main challenges in
the biomimetic fabrication of aligned collagen fibrils
mirroring corneal stromal inner structure. Silk has
shown excellent optical clarity and more importantly,
controllable degradation rates and mechanical proper-
ties, unlike other natural polymers. In termsof pursuing
cell-biomaterial interactions, the ease of patterning and
chemical modification enables silk to outweigh other
materials. Derived from collagen, gelatin does not show
any better overall performance. Alternatively, chitosan
is easily functionalized and highly biodegradable and
could be more useful when acting as an incorporated
component in blended scaffolds. Despite their excellent
physiological properties, the modification of synthetic
polymers (e.g. RGD, collagen addition) is required to
achieve satisfactory biological performance. Notwith-
standing, they have significant potential as artificial
corneas or substrates for various kinds of corneal cells,
with most of the candidates mentioned above showing
favorable ability to support the growth and delivery of
diverse cell types.
In spite of the progress and promise of a bioengi-
neered cornea, there are many challenges to overcome.
Firstly, human trials are necessary to definitively
determine the efficacy of corneal substitutes. Currently,
clinical trials of bioengineered corneal substitutes are
by-and-large limited to collagen-based materials with
other materials rarely reported [177, 188]. A 12 month
follow-up of LSC therapy and long-term corneal regen-
eration conducted on113 eyes of 112 patientswith burn
related LSC deficiency showed that the total success rate
by one year, as characterized by a transparent, avas-
cular, and stable corneal surface being restored, was
76.6% [189]. A significant finding is that a minimum
number of 3000 p63-bright holoclone-forming LSCs is
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essential and suggested for clinical success of auto-
logous LSC transplantation [189]. Most bioengineered
substitutes are merely designed to fulfill the require-
ments of transparency, biocompatibility and biode-
gradability, with other important properties such as
innervation and regeneration often overlooked. Cor-
neal innervation is critical to corneal sensation and pro-
tection, with optimal nerve density important for
wound healing. Notwithstanding, some studies have
demonstrated the reinnervation of collagen-based
grafts in vivo [66, 74–77, 177], but reports on neural
regrowth of other materials remain limited. Notably,
Wang et al recently developed an innervated silk-based
multilayered corneal epithelium and stroma including
innervation induced and directed by nerve growth fac-
tor in vitro. Increased IVL, GJA4, ALDH3A1 and KERA
expression of innervated models indicated better cor-
neal epithelial maturity and corneal stromal transpar-
ency compared to non-innervated ones, which further
demonstrated the key role of innervation in the main-
tenance of the corneal epithelium and stroma (figure 7)
[190]. Then, while a great number of studies have
reported the effect of the characteristics of scaffolds
(composition, structure, pattern, etc) on in vitro
response, fewwere carried out on the influence of those
on the in vivo response, which might be more sig-
nificant when pursuing the best substitute for corneal
tissue. The use of a porous structure [101] or combining
propionamide [106], for instance, tends to induce a fas-
ter biodegradation rate in an animal model. Finally,
recognition of the structural distinction of different
cornea tissue layers has underscored the need for a vari-
ety of strategies to develop substitutes amenable to gen-
erating each layer. Despite the challenges, progress is
being made towards identifying efficacious and acces-
sible substrates capable of supporting cell growth and
delivery, and tissue restoration towards recapitulating
bona fide corneal tissue. Most challenging, has always
been the fabrication of a stroma consisting of parallel
lamellar sheets and a highly ordered microstructure of
collagen fibrils with functional keratocytes and proteins
to mimic the cornea stroma, as a result of the anatomi-
cal and functional importance of the stroma. Once it is
achieved, bioengineering a whole-thickness cornea
should be much easier, since substantial progress has
been claimed on the regeneration of the cornea
Figure 7. Schematics of human cornea and an in vitro 3D corneal tissuemodel. Scale bars=3 mm. Reprinted from [190], copyright
(2017), with permission fromElsevier.
21
Biomed.Mater. 13 (2018) 032002 ZChen et al
epithelium and endothelium, which aremainly cell lay-
ers. Engineering corneal substitutes with all layers for
full-thickness PKP procedure would be preferable.
Currently, protocols to fabricate a whole-thickness cor-
nea are cell-free and cell-encapsulated membranes.
Recently, electrochemically compacted collagen matri-
ces with improved strength and modulus after being
crosslinked by EDC/NHS or genipin demonstrated
highly dense structure and comparable transparency to
the native cornea, suggesting great potential for corneal
tissue engineering [191]. Apart from collagen gel,
human keratocytes encapsulated into fibrin-agarose
scaffolds with similar transparency, and UV absorption
characteristics to the native human cornea [192, 193],
have been built into a whole cornea by seeding corneal
epithelial cells and endothelial cells on each side [194].
Zhang et al recently developed a biomimetic 3D corneal
model by loading patterned silk films and collagen gel
onto a dome-shaped post and more interestingly, the
effect of mechanical strain on human keratocyte phe-
notype and ECM formation was investigated (figure 8).
The keratocyte alignment and ECM arrangement were
directed by the topography of the silk films and com-
pared with traditional 2D culture, and higher expres-
sion of keratocyte marker and expression of ECMwere
detected in the 3Dmodel. Moreover, higher expression
of keratocyte marker was also observed on a 3% dome-
shapedmechanical strain corneamodel compared with
flat-shaped strain [158]. Gouveia et al successfully fabri-
cated auto-generated scaffold-free 3D corneal equiva-
lents by stacking HCS cell sheets collected from PA
coatings and subsequently culturing the multilayered
cell sheets for 21 days. The corneal equivalent was not
only transparent but well integrated into rabbit models
after 9 months. Other interesting findings included the
alignment of stromal cells and secreted collagen fibrils
were directed by the topography of growth substrates
with different anisotropies, with tissues comprising
aligned collagenfibrils tending to be thicker, denser and
more resistant to proteolytic degradation compared to
those comprising randomly oriented fibrils. This work
is definitely significant for fabricating a scaffold-free
human tissue thatmimics the corneal stroma with con-
trolled structure and functional properties [195].
In spite of the challenges, there is little doubt that
corneal implants will be partly or completely engi-
neered in vitro as qualified alternatives to current treat-
ments, thereby addressing the present shortfall in
donor corneas. The rapid advancement in biomater-
ials, cell biology and tissue engineering methods such
as bioprinting will facilitate the formation of durable
biomimetic structures that are customized to the indi-
vidual needs of recipients, improving transplant dur-
ability and functionality, and ultimately the quality of
life for the large numbers of patients worldwide suffer-
ing from corneal blindness.
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